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Aim To assess patients’ knowledge about prescription medi-
cines they are taking and their view on how much commu-
nity pharmacist counseling contributed to their knowledge.
Methods An observational study was designed to obtain 
information about patients’ knowledge, their view on phar-
macist counseling, and physicians’/pharmacists’ provision of 
information. This study used a specifically designed ques-
tionnaire, which served as an interview guide. 400 patients 
picking up a prescription medicine were structurally inter-
viewed upon leaving one of the 20 randomly chosen Slo-
venian pharmacies. The interviews took place in November 
and December 2013.
Results Patients were familiar with general information 
about the medicines and their application (93%-100% of pa-
tients). Knowledge about considerations (16% of patients) 
and adverse effects (20% of patients) was limited. Factors 
associated with patient knowledge were physicians’/phar-
macists’ adequate provision of information (β = 0.259), pa-
tient’s age (β = - 0.149), patient’s education (β = 0.100), and 
prescription type (β = -0.104). Patients’ responses were most-
ly consistent with the Summaries of Product Characteristics 
(72%-96% of responses). However, 42% of responses to the 
question about taking medicine with meals were incorrect. 
Pharmacists routinely informed the patients about medica-
tion purpose, dose, application rate, and timing of medi-
cation (in 72%, 89%, 89%, and 77% of cases, respectively). 
Other information was rarely offered. Patients with new pre-
scriptions received significantly more counseling (pharma-
cist counseling score 5.9, 5.2, and 4.7 of maximum 10 for 
new, regular, and refill prescriptions, respectively, P = 0.001) 
and obtained adequate labeling (69%, 26%, and 17% of pa-
tients for new, regular and refill prescriptions, respectively, 
P < 0.001) than patients with regular or refill prescriptions.
Conclusion Patients were familiar with basic information 
about administration of their prescription medicines, but 
lacked knowledge about medication safety. This could be 
attributed to pharmacist counseling, which primarily fo-
cused on medicine use instructions.
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The number of prescriptions dispensed in Slovenian com-
munity pharmacies has gradually increased, with more 
than 16.5 million prescriptions in 2013 and an average of 
8 prescriptions per inhabitant per year (1). Patients, par-
ticularly those who use multiple medicines, are likely to 
experience drug-related problems, which might increase 
morbidity, mortality, and hospital admissions, all having 
substantial economic impact (2-5).
Patient education ensures optimal use of medicines and 
minimizes drug-related problems. Patients’ knowledge 
enhances active participation in therapy, thus increas-
ing adherence and ultimately leading to better treatment 
outcomes (6-10). A fundamental source of patient educa-
tion about medicines are community pharmacists, as they 
typically offer the last health professional advice before pa-
tients start taking their medicines. Therefore, their respon-
sibility is to provide medication counseling every time they 
dispense a prescription medicine. Effective counseling in-
cludes two fundamental processes: asking patients what 
they already know and filling in knowledge gaps (11,12).
Community pharmacy services in Slovenia are provided by 
either public pharmaceutical institutions (founded by local 
authorities) or privately-owned pharmacies. Patients can 
collect their prescription medicines in any of the pharma-
cies. At the end of 2013, there were 319 community phar-
macies (pharmacy density of 6455 inhabitants per phar-
macy) and 52 active pharmacists per 100 000 inhabitants 
(13,14). Costs of prescription medicines are covered by a 
combination of the compulsory and additional voluntary 
health insurance (15). All pharmacies are members of the 
Chamber, which serves as a supervisory body.
Good pharmacy counseling improves patients’ knowl-
edge and their use of medicines (7,8,10). Several obser-
vational studies evaluated quality of counseling by fo-
cusing on the counseling process or patients’ knowledge 
(6,11,16-21). However, none of these studies attempted 
to relate patient knowledge and pharmacist counseling 
as viewed by patients. The aim of the current study was 
to assess patients’ knowledge about prescription medi-
cines they are taking and to identify their view of how 
much community pharmacist counseling contributed to 
their knowledge.
ParticiPaNts aNd MetHods
This cross-sectional survey used structured interviews 
with patients exiting randomly chosen pharmacies. 
Ethical approval for the study was obtained from the Na-
tional Medical Ethics Committee.
Questionnaire design
This study used a specifically designed questionnaire 
(Supplementary material), which served as an interview 
guide. The content of the questionnaire was derived from 
pharmacy counseling literature (22-24). The question-
naire comprised 10 open-ended questions dealing with 
patients’ knowledge about medications. The first 8 ques-
tions focused on specific counseling elements regard-
ing the medication: purpose, dose, application rate, tim-
ing, route of administration, taking with meals, duration of 
therapy, and recognition of medication effectiveness. The 
last 2 were general questions about considerations and 
adverse effects (ie, “What do you know about …?”). There-
fore, responses to the question about considerations could 
include interactions, contraindications, precautions, warn-
ings, and so on. Responses to the question about adverse 
effects included adverse effects, associated time frames, 
how to prevent or minimize adverse effects, and so on.
The ten open ended questions were followed by 3 yes/no 
questions. These examined patients’ view on pharmacists’ 
contribution to their knowledge about a specific counsel-
ing element. The first question asked whether the pharma-
cist informed them about a specific counseling element at 
their most recent pharmacy visit. If the answer was nega-
tive, the second question asked whether the pharmacist 
specifically checked if the patient already possessed this 
knowledge. The third question addressed the patients’ cu-
mulative experiences with their physicians and pharma-
cists, asking if their health care providers adequately in-
formed them about a specific counseling element. In this 
respect, information needs were identified. The question 
included physicians in case patients did not remember 
who exactly provided that type of information during their 
treatment. The last question addressed any other, so far 
unexpressed, important medication information that the 
pharmacists provided during the most recent pharmacy 
visit. The provision of a medication label or any other writ-
ten information was also investigated.
Other medication-specific data included the name, dos-
age strength, and prescription type (new, regular, refill). 
New prescriptions were those written for first-time users. 
Regular prescriptions were prescriptions for the medicines 
that the patient previously used, but with no refills. Refill 
prescriptions were prescriptions for the medicines that the 
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patient previously used, with refills. Other patient-specific 
data included age, sex, education, income, patient’s cur-
rent number of prescription medicines, patient’s assess-
ment of current health status, and patient’s assessment of 
pharmacist counseling. Relevant experts with experience 
in pharmacy practice were consulted regarding the con-
tent of the questionnaire. Afterwards, the drafted question-
naire was tested in a pilot study on a convenient sample of 
patients to establish its face and content validity.
sample
The exit survey involved patients leaving a community 
pharmacy. The sample had to be large enough to provide 
95% confidence interval of a single proportion with a span 
of 0.1 (from -0.05 to +0.05), assuming a proportion of 0.5 
(50% counseling rate). The calculated required sample size 
was 385, which was rounded up to 400 (25). Using the Ex-
cel randomization function a random sample of 20 Slove-
nian pharmacies was selected from a list of all Slovenian 
pharmacies. Thus 20 patients per pharmacy were needed 
to be recruited. The selected pharmacies received a writ-
ten notification about the study, its aims and design. In 
the notification, the interview time was scheduled in three 
months. Pharmacies were informed that all data would 
be anonymous and strictly confidential. They also had the 
right to refuse participation.
study procedure
Patient interviews were conducted by final-year pharmacy 
students (N = 10) who had undergone a one-day training 
course designed to familiarize them with the study. Inter-
viewers approached patients leaving the pharmacy and fil-
tered out anyone who did not pick up a prescription. Inter-
viewers explained the study aims, assured anonymity, and 
requested consent. Each interview referred to one of the 
medicines that the patient received at the most recent phar-
macy visit. If a patient received multiple prescription medi-
cines, one was randomly selected. Some of the patients re-
fused to participate, but we did not register their number.
The interviewers followed the interview guide, writing 
down patients’ answers to the open-ended questions ver-
batim. The patients were allowed to use any written mate-
rial they obtained at the pharmacy (including the patient in-
formation leaflet) to answer the questions. The interviewer 
noted if the patient needed to consult the written material 
to answer correctly. At the end of the interview, the patients 
were thanked for their participation. All interviews took 
place in November and December 2013. After the comple-
tion of the interviews, the noted patients’ responses were 
checked for consistency with Summaries of Product Charac-
teristics (SmPCs). If the patient response matched the SmPC 
(eg, medication purpose the patient stated was listed in the 
SmPC), the response was labeled as consistent.
scoring system
Three separate scores were calculated. The first score eval-
uated patients’ knowledge, based on their answers to the 
open-ended questions. Patients received points if they 
knew a specific counseling element and their response 
was consistent with the corresponding SmPC. The second 
score assessed the pharmacist counseling. Pharmacists re-
ceived points if their patients stated they were explained 
or asked about a specific counseling element. The third 
score assessed the adequacy of information provided by 
physicians and pharmacists during treatment. Physicians 
and pharmacists received points if the patients thought 
they received adequate information about a specific coun-
seling element. The same criteria were used for all three 
scores: each counseling element received 1 point, with a 
maximum of 10 points (Table 1).
statistical analysis
Standard descriptive statistics measures (mean, standard 
deviation [SD], median [5th-95th percentile]) were used. 
table 1. scoring system for evaluation of patient knowl-
edge about their prescriptions, pharmacist counseling at the 
most recent pharmacy visit, and adequacy of physician and 
pharmacist information during treatment. For each item, 1 
was assigned if judged satisfactory, 0 otherwise, to yield a total 










Medication purpose 1 1 1
Dose 1 1 1
Rate of application 1 1 1
Timing of medicine 1 1 1
Route of administration 1 1 1
Taking with meals 1 1 1




Considerations 1 1 1
Adverse effects 1 1 1
Total 10 10 10
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Normality of distribution was tested by Smirnov-Kolmog-
orov test and appropriate nonparametric methods were 
applied. Differences in quantitative values between two 
groups were tested by a Mann-Whitney test with Bonfer-
roni correction. Differences in categorical variables were 
tested using χ2 test.
A multiple linear regression was performed to determine 
factors associated with patients’ knowledge. Therefore, the 
patients’ knowledge score was set as a dependent variable. 
The patient’s prescription type, number of current medi-
cines, sex, age, education, income, assessment of current 
health status, assessment of pharmacist counseling, phar-
macist counseling score, and physician/pharmacist in-
forming score were used as factors. Dummy variables were 
used in cases of categorical variables with more than two 
categories. First, bivariate correlations between the fac-
tors and patient knowledge score were calculated. Those 
with non-significant correlations were excluded from fur-
ther analysis. The remaining factors were entered into the 
regression model. The forced entry method of regression 
was used (SPSS: Enter method). Multicollinearity was ex-
amined by the variance inflation factors. Statistical analy-
sis was performed in Microsoft Excel 2010 and SPSS v. 22 
(26,27). A significance level below 0.05 was considered sta-
tistically significant.
results
All twenty contacted pharmacies agreed to participate 
in the study. Twelve pharmacies were from an urban and 
eight pharmacies from a rural setting.
sociodemographic data
On the 1-5 rating scale (1 = poor, 5 = excellent), patients as-
sessed their current health status with the median [5th-95-
th percentile] of 3 [1.8-5]. The median of the current num-
ber of prescription medicines was 3 [1-8]. According to 
the Anatomical Therapeutic Chemical classification, the 
medicines chosen for the interviews were predominately 
from group C (cardiovascular, N = 94, 24%), N (nervous sys-
tem, N = 65, 16%), and A (alimentary tract and metabolism, 
N = 51, 13%). There was a roughly equal number of new 
and regular prescriptions (149 vs 147) and 103 refill pre-
scriptions. One patient did not know the prescription type 
(Table 2).
Patients’ knowledge
Most patients were familiar with their medication pur-
pose (N = 370, 93% of valid responses), dose (N = 390, 
99%), application rate (N = 384, 96%), timing (N = 386, 





missing data   2 (1)
education, n (%)
primary school or less  71 (18)
secondary school 228 (57)
college  53 (13)
university or more  41 (10)
missing data   7 (2)
Monthly income in eur, n (%)
less than 650 175 (44)
650-800  64 (16)
800-1000  49 (12)
1000-1300  33 (8)
more than 1300  22 (6)
missing data  57 (14)
age, median (range), n (%)
age in years  57 (12-92)
missing data   8 (2)
table 3. Multivariate regression of patient knowledge score on patients’ sociodemographic data, pharmacist counseling score, and 
physician/pharmacist informing score. Factors that showed significant bivariate correlation with patient knowledge were entered 
into the regression model
Factor b 95% confidence interval standardized β P
(Constant) 6.468  5.804, 7.132
Prescription type -0.257 -0.503, -0.010 -0.104 0.042
Number of current medicines -0.019 -0.064, 0.025 -0.046 0.395
Sex 0.139 -0.071, 0.349  0.064 0.195
Age -0.009 -0.016, -0.002 -0.149 0.011
Education 0.352  0.005, 0.699  0.100 0.047
Pharmacist counseling -0.007 -0.047, 0.034 -0.017 0.744
Physician/pharmacist adequate informing 0.154  0.094, 0.214  0.259 <0.001
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97%), and administration route (N = 397, 100%). Few-
er, but still a high percentage of patients knew how to 
determine the therapy duration (N = 310, 78%) and to 
recognize medication effectiveness (N = 341, 86%). 358 
patients answered the question about taking their medi-
cine with meals; however, 150 gave responses that were 
not consistent with the corresponding SmPCs. The most 
common mistake (92 out of 150 patients) was the answer 
that the medicine should be taken before or after a meal 
or even on an empty stomach when the SmPC stated 
that medicine could be taken irrespective of food intake. 
While this was not a pharmacotherapy concern, it rep-
resented a burden for patients who were unnecessarily 
preoccupied with taking their medicine with meals. Six-
ty-five patients (16%) knew about considerations. Mostly, 
they were familiar with contraindications (N = 16), inter-
actions with alcohol (N = 11), and interactions with food 
(N = 10). Only 79 patients (20%) knew something about 
the adverse effects of their medicine. Most knew the 
possible adverse effects (N = 73), and a few knew how to 
prevent or minimize adverse effects (N = 10) (Figure 1). 
Nineteen patients (5%) used the written material they 
obtained at the pharmacy to answer the questions. Most 
used it for the question about adverse effects. The aver-
age score ± standard deviation for patient knowledge 
was 7.3 ± 1.2 points.
Table 3 shows the factors that significantly correlated 
with patients’ knowledge and were thus used in the re-
gression model. The model explained 14.0% of variance 
of patients’ knowledge (R = 0.375, N = 378, P < 0.001). All 
variance inflation factors were below 1.2, indicating mi-
nor multicollinearity among the factors. The strongest 
factor associated with patient knowledge was provision 
of adequate informing from the physicians or pharma-
cists (β = 0.259, 6.0% of variance explained). Other sta-
tistically significant factors were age (β = -0.149, 1.5% of 
variance explained), prescription type (β = -0.104, 1.0% 
of variance explained), and education (β = 0.100, 0.9% of 
variance explained). Patients with refill prescriptions dis-
played lower level of knowledge than other patients. Pa-
tients with university or higher education demonstrated 
better knowledge scores. Other factors were not signifi-
cantly associated with patients’ knowledge.
Figure 1. Patient knowledge of different counseling elements, pharmacist counseling at patients’ most recent visit to the pharmacy, 
and physician/pharmacist adequate informing. For each counseling element, the percentage of patients who had knowledge of a 
counseling element, the percentage of patients who stated they were offered information or verification for a counseling element 
at their most recent visit to the pharmacy, and the percentage of patients who thought that they were adequately informed about a 
counseling element during their treatment are shown.
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Pharmacist counseling at the most recent visit to the 
pharmacy
Patients reported whether the pharmacist explained or 
checked the patients’ knowledge of a specific counseling 
element at their most recent visit to the pharmacy (Figure 
1). Pharmacists most often discussed medication purpose 
(N = 287, 72% of valid responses), dose (N = 354, 89%), ap-
plication rate (N = 354, 89%), and timing (N = 308, 77%). 
About half of the patients stated they received information 
or verification about administration route (N = 214, 54%) 
and dosage time in relation to food (N = 187, 47%). Other 
information was rarely offered. Ninety-seven (24%) patients 
were given information on at least one consideration. Simi-
larly, 68 (17%) patients were counseled on adverse effects. 
31 patients (8%) claimed they received no counseling on 
any of the counseling elements. Patients assessed pharma-
cist counseling on a 5-point rating scale (1 = poor, 5 = ex-
cellent). The average rating was 4.5 ± 0.8.
With respect to prescription type, most counseling was 
performed for patients with new prescriptions. The differ-
ence in scores for pharmacist counseling (new vs regular, 
new vs refill) were significant (P = 0.03 and P = 0.003, respec-
tively). There were no significant differences in pharmacist 
counseling scores between regular and refill prescriptions 
(P = 0.53). Overall, the average score for pharmacist coun-
seling was 5.3 ± 2.7 points.
Pharmacists provided medication labels for 157 patients 
(39%). 6 of them could not read the pharmacist’s handwrit-
ing. Patients often commented that they did not need a 
medication label, because they already were familiar with 
their medicines. A small proportion of patients who had 
previously used their medicines were given medication 
labels (38 out of 147 with regular prescriptions, 17 out of 
103 with refill prescriptions). On the other hand, 69% (102 
out of 147) of patients with a new prescription received a 
medication label (Figure 2). The differences in label provi-
sion were significant (χ2 = 89.2, P < 0.001).
adequate informing by physician and pharmacist at 
any time during treatment
Almost all patients were satisfied with information on 
medication purpose, dose, application rate, and timing. 
Most felt that they were adequately informed about the 
administration route, taking of the medicine with meals, 
therapy duration, and the way to recognize medication 
effectiveness. However, about half of the patients want-
ed more information about adverse effects and medicine 
considerations. The average score for physician and phar-
macist informing was 8.2 ± 2.4 points (Figure 1).
discussioN
The results of this study suggest that Slovenian patients un-
derstand basic information about their prescription medi-
cines; however, they lack knowledge about medication 
safety. This lack of knowledge can be attributed to pharma-
cist counseling, which, according to patients’ assessment, 
mainly focuses on medication administration and neglects 
medication considerations or adverse effects.
Patients’ knowledge
Patients showed consistent knowledge about medication 
purpose, dose, application rate, timing, and administra-
tion route. Thus, a large proportion of patients knew how 
to administer their medicine. Other studies that assessed 
patient knowledge of prescription medicines also showed 
the highest patients’ scores in these areas (18,20,21).
In contrast to high levels of knowledge about administra-
tion of medicines, patients in this study showed a serious 
knowledge deficiency about medicine considerations and 
adverse effects. Patients were considered knowledgeable 
about a counseling element if they could name at least one 
item (eg, one adverse effect). Despite this lenient criterion, 
only one out of six patients knew something about consid-
erations and one out of five patients knew something about 
Figure 2. Pharmacists’ provision of medication labels accord-
ing to the prescription type. Numbers represent the percent-
ages of patients who were provided medication labels at their 
most recent pharmacy visit.
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adverse effects. Other studies that evaluated patients’ level 
of knowledge about their prescription found similar results 
(7,20,28). This study showed that lack of knowledge could 
be attributed to the deficiency of pharmacist counseling.
The results of the multiple regression analysis indicated 
that age was negatively associated with patient knowl-
edge. This could be attributed to differences in education 
levels, diminishing cognitive capabilities, differences in val-
ues, psychosocial factors, and possible communication 
impairments (12,18). Thus, pharmacists should tailor their 
counseling to elderly patients (12,29). Patients with univer-
sity or higher education showed better scores for patient 
knowledge, which is consistent with findings from similar 
studies (7,8,20,21). It has been shown that patients with 
higher education better understand counseling about 
their prescription medication (20).
Medication counseling
The level of patients’ knowledge about their prescription 
medicines can be better understood by examining the 
counseling they received. Patients indicated they were 
frequently given directions for medication use, whereas 
information on considerations and adverse effects was 
seldom provided. Several studies report omission of drug 
safety issues during counseling (2,22,23,30). This negli-
gence results in knowledge deficiency and a demand for 
more information. In this study, 43% of patients felt that 
they were inadequately informed about considerations 
and 48% felt the same about adverse effects. Similarly, Nair 
et al (31) found that patients in focus groups expressed 
frustration about not getting enough information about 
adverse effects and risks.
Properly informed patients are likely to feel more control 
over and less apprehension about their medication use. 
They are more attentive to adverse effects, which they de-
tect more quickly than patients who do not receive ade-
quate information (29). In this respect, early contact with 
health care providers can prevent serious adverse effects. 
Additionally, patients who are not told about possible ad-
verse effects are more likely to be intimidated when read-
ing them in the patient information leaflet (29). Studies by 
Lamb et al (32) and Howland et al (33) also indicate that 
counseling patients about adverse effects does not in-
crease the incidence of adverse effects or decrease therapy 
adherence. Hence, pharmacists should be advised to pay 
greater attention to counseling about drug safety without 
creating an information overload (29).
This study indicated that patients knew more about their 
prescription medicines than what they learned at their 
most recent pharmacy visit. The largest discrepancies be-
tween patient knowledge and perceived pharmacist coun-
seling were observed in cases of recognizing medication 
effectiveness, route of administration, and taking of medi-
cines with meals. For example, 86% of the patients knew 
how to recognize their medication effectiveness, while 
only 25% indicated they received counseling about this 
topic at their most recent pharmacy visit. In this respect, 
adequate informing by the physician or pharmacist dur-
ing treatment seemed to have a greater effect on patient 
knowledge than did pharmacist counseling at the most 
recent pharmacy visit. The results of the regression analy-
sis, in which physician and pharmacist informing was a sig-
nificant factor associated with patient knowledge, support 
this finding.
Consistent with other studies, patients who collected new 
prescriptions received significantly more counseling than 
those who collected regular or refill prescriptions (2,30). 
This finding might be explained by lack of patients’ interest 
and their belief that medication counseling for regular or 
refill prescriptions was unnecessary (2,22). Another reason 
might be that the pharmacist assumed that patients with 
chronic conditions already knew how to properly use their 
medicines (22). This study did not support this assumption, 
as the prescription type was a significant factor associated 
with medication knowledge. The average patient knowl-
edge scores for new, regular, and refill prescriptions were 
7.5, 7.4, and 7.1, respectively. Patients with refill prescrip-
tions thus demonstrated significantly lower knowledge 
scores. Since these patients usually see their physician only 
once a year, it is the responsibility of a community pharma-
cist to follow these patients and provide adequate coun-
seling. This study suggests community pharmacists should 
improve their counseling for patients with refill prescrip-
tions, thus enhancing their knowledge.
Many patients in this study stated they did not receive 
counseling about important medication information at 
their most recent pharmacy visit. Nevertheless, patients 
rated pharmacist counseling 4.5 out of 5 on average, and 
63% of those surveyed assessed counseling with the high-
est possible score. Despite expressing a need for further in-
formation, especially about safety issues, patients seemed 
satisfied with the pharmacist counseling they received. 
Patient satisfaction studies reported similar results (34-
36). These findings might be explained by patients’ 
tendency to accept their care until something unac-
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ceptable happens (35). Patients are also generally reluctant 
to express criticism or concern (37).
Medication labels were provided for 39% of patients, with 
significant differences relating to prescription type. Low 
rates of medication label provision for the regular and re-
fill prescriptions are understandable. Medication labels in 
Slovenia mostly contain information on dose and dosing 
interval, and patients are usually familiar with this infor-
mation. However, 31% of patients with new prescriptions 
did not receive medication labels. Providing written infor-
mation in addition to verbal counseling enhances patient 
knowledge and encourages safer medication use (29). Fur-
thermore, the “Rules on the Classification, Prescribing and 
Dispensing of Medicinal Products for Human Use,” which 
are valid in Slovenia, declare that each dispensed medicine 
should be supplied with a label (38). In this respect, phar-
macists can improve their provision of medication labels 
and thus fulfill their professional and legal obligations.
limitations and conclusion
The researchers checked the consistency of patient re-
sponses with SmPCs. To verify the accuracy of patients’ 
recollections, more information on patients and their dis-
eases would be needed. Furthermore, patients may un-
derestimate the types of information they get since they 
have forgotten the actual information they received (22). 
Nevertheless, Schommer et al (24) found that patient sur-
veys were a useful way to collect data about counseling, 
though they stipulated that questions must be careful-
ly worded. In summary, patients knew basic information 
about the administration of their prescription medicines, 
but they lacked knowledge about medication safety. This 
deficiency could be attributed to counseling, which pri-
marily focused on medicine use instructions.
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